Compile Data Set for Download or QSAR
Report error Found 44 Enz. Inhib. hit(s) with all data for entry = 10250
TargetSerine/threonine-protein kinase Nek7(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 522958BDBM522958(US11161852, Compound 1 | 1-(4-(4-amino-7- (oxetan-...)
Affinity DataIC50: 225nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase Nek7(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 523015BDBM523015(US11161852, Compound 45 | 1-(4-(4-amino-7- cyclopr...)
Affinity DataIC50: 225nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase Nek7(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 523003BDBM523003(US11161852, Compound 28 | 1-(4-(4-amino-7- cyclopr...)
Affinity DataIC50: 225nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase Nek7(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 522987BDBM522987(US11161852, Compound 10 | 1-(4-(4-amino-7- cyclopr...)
Affinity DataIC50: 225nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase Nek7(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 523005BDBM523005(US11161852, Compound 30 | 1-(4-(4-amino-7- cyclopr...)
Affinity DataIC50: 225nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase Nek7(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 522989BDBM522989(US11161852, Compound 12 | 1-(4-(4-amino-7- cyclopr...)
Affinity DataIC50: 225nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase Nek7(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 523007BDBM523007(US11161852, Compound 35 | 1-(4-(4-amino-7- cyclopr...)
Affinity DataIC50: 225nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase Nek7(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 522991BDBM522991(US11161852, Compound 14 | 1-(4-(4-amino-7-(2- hydr...)
Affinity DataIC50: 225nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase Nek7(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 522995BDBM522995(US11161852, Compound 19 | 1-(4-(4-amino-7- cyclopr...)
Affinity DataIC50: 400nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase Nek7(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 522999BDBM522999(US11161852, Compound 23 | 1-(4-(4-amino-7- cyclopr...)
Affinity DataIC50: 400nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase Nek7(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 522959BDBM522959(US11161852, Compound 6 | 1-(4-(4-amino-7- cyclopro...)
Affinity DataIC50: 400nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase Nek7(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 523002BDBM523002(US11161852, Compound 26 | 1-(4-(4-amino-7-(1- meth...)
Affinity DataIC50: 400nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase Nek7(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 523019BDBM523019(US11161852, Compound 53 | 1-(4-(4-amino-7- cyclobu...)
Affinity DataIC50: 400nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase Nek7(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 523004BDBM523004(US11161852, Compound 29 | 1-(4-(4-amino-7- cyclopr...)
Affinity DataIC50: 400nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase Nek7(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 522988BDBM522988(US11161852, Compound 11 | 1-(4-(4-amino-7- cyclopr...)
Affinity DataIC50: 400nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase Nek7(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 523006BDBM523006(US11161852, Compound 31 | 1-(4-(4-amino-7- cyclopr...)
Affinity DataIC50: 400nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase Nek7(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 522990BDBM522990(US11161852, Compound 13 | 1-(4-(4-amino-7- cyclopr...)
Affinity DataIC50: 400nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase Nek7(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 523022BDBM523022(US11161852, Compound 56 | 1-(4-(4-amino-7-(1- meth...)
Affinity DataIC50: 400nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase Nek7(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 523012BDBM523012(US11161852, Compound 42 | 1-(4-(4-amino-7- cyclopr...)
Affinity DataIC50: 1.00E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase Nek7(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 523014BDBM523014(US11161852, Compound 44 | 1-(5-(4-amino-7- cyclopr...)
Affinity DataIC50: 1.00E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase Nek7(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 523000BDBM523000(US11161852, Compound 24 | 1-(4-(4-amino-7- (pyridi...)
Affinity DataIC50: 1.00E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase Nek7(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 523001BDBM523001(US11161852, Compound 25 | 1-(4-(4-amino-7- (pyridi...)
Affinity DataIC50: 1.00E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase Nek7(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 522972BDBM522972(US11161852, Compound 7 | 1-(4-(4-amino-7- cyclopro...)
Affinity DataIC50: 1.00E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase Nek7(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 522983BDBM522983(US11161852, Compound 8 | 1-(4-(4-amino-7- cyclopro...)
Affinity DataIC50: 1.00E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase Nek7(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 523023BDBM523023(US11161852, Compound 58 | 1-(4-(4-amino-7- cyclobu...)
Affinity DataIC50: 1.00E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase Nek7(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 523008BDBM523008(US11161852, Compound 36 | 1-(4-(4-amino-7- cyclopr...)
Affinity DataIC50: 1.00E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase Nek7(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 523009BDBM523009(US11161852, Compound 38 | 1-(4-(4-amino-7- cyclopr...)
Affinity DataIC50: 1.00E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase Nek7(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 522994BDBM522994(US11161852, Compound 18 | 1-(4-(4-amino-7- cyclopr...)
Affinity DataIC50: 1.50E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase Nek7(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 523026BDBM523026(US11161852, Compound 62 | US11713321, Example 62)
Affinity DataIC50: 1.50E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase Nek7(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 522996BDBM522996(US11161852, Compound 20 | 1-(4-(4-amino-7- cyclopr...)
Affinity DataIC50: 1.50E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase Nek7(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 522997BDBM522997(US11161852, Compound 21 | 1-(4-(4-amino-7- cyclopr...)
Affinity DataIC50: 1.50E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase Nek7(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 522998BDBM522998(1-(4-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50: 1.50E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase Nek7(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 523010BDBM523010(US11161852, Compound 40 | 1-(6-(4-amino-7- cyclopr...)
Affinity DataIC50: 1.50E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase Nek7(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 523011BDBM523011(US11161852, Compound 41 | 1-(4-(4-amino-7- cyclopr...)
Affinity DataIC50: 1.50E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase Nek7(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 523013BDBM523013(US11161852, Compound 43 | 1-(4-(4-amino-7- cyclopr...)
Affinity DataIC50: 1.50E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase Nek7(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 523016BDBM523016(US11161852, Compound 48 | 1-(5-(4-amino-7- cyclopr...)
Affinity DataIC50: 1.50E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase Nek7(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 523017BDBM523017(US11161852, Compound 49 | 1-(4-(4-amino-7- cyclopr...)
Affinity DataIC50: 1.50E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase Nek7(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 523018BDBM523018(US11161852, Compound 50 | 1-(4-(4-amino-7- cyclopr...)
Affinity DataIC50: 1.50E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase Nek7(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 523020BDBM523020(US11161852, Compound 54 | 1-(4-(4-amino-7- cyclopr...)
Affinity DataIC50: 1.50E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase Nek7(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 523021BDBM523021(US11161852, Compound 55 | 1-(4-(4-amino-7-c yclopr...)
Affinity DataIC50: 1.50E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase Nek7(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 522992BDBM522992(US11161852, Compound 15 | 1-(4-(4-amino-7- cyclopr...)
Affinity DataIC50: 1.50E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase Nek7(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 523024BDBM523024(US11161852, Compound 59 | 1-(6-(4-amino-7- cyclopr...)
Affinity DataIC50: 1.50E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase Nek7(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 522993BDBM522993(US11161852, Compound 16 | 1-(4-(4-amino-7- cyclopr...)
Affinity DataIC50: 1.50E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/20/2022
Entry Details
US Patent

TargetSerine/threonine-protein kinase Nek7(Human)
Halia Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 523025BDBM523025(US11161852, Compound 60 | 1-(4-(4-amino-7- cyclopr...)
Affinity DataIC50: 1.50E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/20/2022
Entry Details
US Patent